Squeeze Report — June 23, 2026
Biotech dominates the squeeze radar today, with RZLT and TGTX leading a pack of high-conviction clinical-stage names. The clustering of binary catalysts—from RZLT’s upLIFT data to BHVN’s regulatory update—suggests a sector-wide volatility event is brewing, while ARRY and SEI offer non-biotech counterpoints with their own earnings-driven dislocation.
Today's top short-squeeze candidates
- #1RZLTRezolute, Inc. Common Stock (N80
A 54% rally on interim data hasn’t shaken a 20.8% short interest, setting up a powder-keg into the upLIFT topline readout.
SI 21%DTC 11.9$5.15+54% 20dHealthcare - #2NEONeoGenomics, Inc. Common Stock80
36% of float sold short · 6.9 days to cover · +23% over 20 days
SI 36%DTC 6.9$11.20+23% 20dHealthcare - #3GOGrocery Outlet Holding Corp. C79
28% of float sold short · 7.7 days to cover · +17% over 20 days
SI 28%DTC 7.7$9.36+17% 20dConsumer Defensive - #4BEAMBeam Therapeutics Inc. Common79
23% of float sold short · 11.7 days to cover · +28% over 20 days
SI 23%DTC 11.7$35.53+28% 20dHealthcare - #5GPGIGPGI, Inc.79
36% of float sold short · 15.8 days to cover · +20% over 20 days
SI 36%DTC 15.8$14.34+20% 20dIndustrials - #6LQDALiquidia Corporation Common St79
16% of float sold short · 7.8 days to cover · +22% over 20 days
SI 16%DTC 7.8$75.49+22% 20dHealthcare - #7ORKAOruka Therapeutics, Inc. Commo79
24% of float sold short · 5.0 days to cover · +45% over 20 days
SI 24%DTC 5.0$85.38+45% 20dHealthcare - #8MBCMasterBrand, Inc.78
28% of float sold short · 6.7 days to cover · +13% over 20 days
SI 28%DTC 6.7$8.62+13% 20dConsumer Cyclical - #9PTCTPTC Therapeutics, Inc. Common77
15% of float sold short · 11.1 days to cover · +16% over 20 days
SI 15%DTC 11.1$80.96+16% 20dHealthcare - #10PARPAR Technology Corp.77
34% of float sold short · 9.2 days to cover · +7% over 20 days
SI 34%DTC 9.2$15.13+7% 20dTechnology - #11ABSIAbsci Corporation Common Stock77
24% of float sold short · 7.5 days to cover · +65% over 20 days
SI 24%DTC 7.5$8.40+65% 20dHealthcare - #12APGEApogee Therapeutics, Inc. Comm76
AbbVie’s $135.11 buyout traps a large pre-deal short base, creating a narrow-window squeeze into the Q3 close.
SI 18%DTC 9.4$132.55+61% 20dHealthcare - #13RLAYRelay Therapeutics, Inc. Commo76
25% of float sold short · 5.7 days to cover · +27% over 20 days
SI 25%DTC 5.7$17.28+27% 20dHealthcare - #14SEISolaris Energy Infrastructure,76
Elevated 27% short interest faces a Q2 earnings catalyst, but heavy insider selling and cheap borrow cap the urgency.
SI 27%DTC 5.1$82.17+12% 20dEnergy - #15SRPTSarepta Therapeutics, Inc. Com75
27% of float sold short · 9.4 days to cover · +4% over 20 days
SI 27%DTC 9.4$17.65+4% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →